Company Description
NeuroScientific Biopharmaceuticals Ltd (NSB) is an Australian public company developing novel peptide-based pharmaceutical products that target a number of neurological disorders that have high unmet medical needs. The Company’s current R&D program is focused on developing a treatment for stroke-related brain injury and dementia / Alzheimer’s disease, and a diagnostic for early-stage Alzheimer’s disease.
NeuroScientific Biopharmaceuticals Ltd belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.neuroscientific.com.
This a small cap company with market cap of 26 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.
| Earnings | PE | PB | PE growth | |
|---|---|---|---|---|
| Company | 0 | 0 | 5.58 | 0 |
| Market | 0.85 | 22.3 | 1.99 | 0.84 |
| Sector | 1.7 | 39.6 | 5.78 | 0.26 |
Dividend Growth Chart
The following chart shows you how nsb dividend grows in the recent years.